Can You Get Wegovy on the NHS? The Real Picture for 2025 and Beyond

You've been told Wegovy is on the NHS. Here's why you still can't get it from your GP.

Imagine sitting in your GP surgery, having read that Wegovy is now recommended by NICE, and hearing your doctor say they cannot prescribe it. That is the experience of a lot of people in the UK right now, and it is not a mistake. NICE TA875, published in March 2023, recommends semaglutide for weight management, but only within a specialist weight management service that provides multidisciplinary support as part of a structured programme. That means a tier 3 or tier 4 service, not a standard GP appointment. Your GP simply does not have the commissioning authority to write this prescription on their own, even if they want to.

There is also a maximum treatment duration built into the NICE guidance: two years. After that, continuing requires a clinical review inside the specialist service. It is not like a blood-pressure tablet you take indefinitely. The logic is that the medicine works alongside a structured behaviour-change programme, and the two are meant to happen together. In practice, this means the NHS Wegovy pathway is inseparable from the service attached to it.

For a more detailed look at how the commissioning picture works across NHS England, our page on Wegovy and the NHS sets out the regional variation in plain terms.

Who the NHS says should get Wegovy, and the thresholds that catch a lot of people out

Under TA875, NHS Wegovy is recommended for adults who meet all of the following: a BMI of 35 kg/m² or above; at least one weight-related comorbidity (such as prediabetes, type 2 diabetes, high blood pressure, obstructive sleep apnoea, or cardiovascular disease); and referral into a specialist weight management service. People from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds are assessed at thresholds 2.5 kg/m² lower (so 32.5 rather than 35, for example) in line with NHS England's guidance.

NICE also says treatment should be reconsidered if a patient has not lost at least 5% of their body weight after six months at the maintenance dose. That is not a punishment clause; it reflects the evidence that people who respond do so relatively early. If the medicine is not working, continuing it is not the right answer.

Where a BMI of 30 to 34.9 might qualify under the full TA875 criteria, the specialist-service requirement still applies. People in that BMI band are not excluded from Wegovy on the NHS entirely, but referral thresholds and service capacity mean they are less likely to be seen quickly. The availability picture by area varies considerably.

Why the waiting list problem is real and not improving fast

Demand for specialist weight management services across England vastly outstrips current capacity. A medicine being recommended by NICE does not immediately create the clinical infrastructure to deliver it. Referrals have surged since 2023, but tier 3 and tier 4 services are commissioned locally by integrated care boards, meaning provision is uneven, and some areas have waiting times running into years. Scotland, Wales and Northern Ireland each commission weight management services differently, with their own eligibility thresholds, so the picture outside England is its own subject.

None of this is criticism of the NHS; it is a structural lag that takes time to close. But it is worth knowing before you decide how to proceed. If you are wondering about whether your GP or a specialist can prescribe Wegovy directly, that page answers the prescribing-authority question in full. And if the private route interests you, the honest comparison of costs is on our Wegovy price comparison page.

The private alternative: what it involves and what to check

A private prescription for Wegovy is legal and available through regulated online pharmacies. For those who don't meet the NHS BMI or comorbidity thresholds, or who simply cannot face an indeterminate wait, this is how many people are currently accessing treatment. The process involves a clinical consultation with a prescribing-qualified clinician, identity verification, and an assessment of your health history before any medicine is issued. Wegovy is a prescription-only medicine; any seller offering it without that process is operating outside the law, and the MHRA has repeatedly warned about fake weight-loss pens circulating online and via social media.

Before using any online pharmacy, you can verify it on the GPhC's public register in about thirty seconds. It is the simplest safety check available, and worth doing. At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it is submitted. The pen you receive travels in plain, unbranded packaging and arrives via DPD the next working day once approved, it sits in the fridge door like any other medicine until pen day arrives. Our guide on where to get Wegovy in the UK walks through both routes without pushing you toward either.

If you have already been on Wegovy through the NHS or another provider and want to continue, our prescribing and dosage page covers what transfer patients should expect from the clinical review process. And if you want to read more about the treatment itself before making any decision, our Wegovy overview covers the evidence and what to expect.

When you are ready to speak to a clinician, start a free consultation with our prescribers, no commitment required.